HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Premedication and pain relief with Nubain during second trimester therapeutic pregnancy terminations.

AbstractOBJECTIVE:
To determine the analgesic efficacy of the opioid agonist-antagonist Nubain during midtrimester therapeutic terminations with intra-amniotic PGF2 alpha or i.m. administration of the PGE2 derivative sulprostone.
METHOD:
Following osmotic predilatation with laminaria tents patients were given as a premedication 10 mg Valium, 10 mg Nubain and 0.5 mg atropine i.m. prior to prostaglandin treatment, and sequential doses of Nubain during the uterine contractility period. Patients indicated their own perception of uterine pain on a differential graphic rating scale, and the attending physician also evaluated patients' discomfort on a 5-grade scale.
RESULT:
In 55% of the cases patients experienced only 'mild' or 'moderate' pain. The mean induction-to-abortion interval was short (11.6 +/- 1.3 h). The well known gastrointestinal side-effects of the prostaglandins were avoided.
CONCLUSION:
Nubain proved effective in stabilizing patients' condition during intra-amniotic instillation of prostaglandin, effectively relieved uterine pain during the myometrial contractility period, prevented the occurrence of prostaglandin-related side-effects, and provided simple and good anesthesia during instrumental removal of the already detached but retained placenta.
AuthorsL Kovács, J Herczeg, L Szabó
JournalInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (Int J Gynaecol Obstet) Vol. 40 Issue 1 Pg. 51-8 (Jan 1993) ISSN: 0020-7292 [Print] United States
PMID8094351 (Publication Type: Journal Article)
Chemical References
  • Dinoprost
  • Nalbuphine
Topics
  • Abortion, Therapeutic
  • Adult
  • Dinoprost
  • Female
  • Humans
  • Injections, Intramuscular
  • Nalbuphine (administration & dosage, therapeutic use)
  • Pain (drug therapy)
  • Pain Measurement
  • Pregnancy
  • Pregnancy Trimester, Second
  • Premedication
  • Uterus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: